Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/94622
Title: Processing of fine hydroxyapatite powders via an inverse microemulsion route
Authors: Lim, G.K.
Wang, J. 
Ng, S.C. 
Gan, L.M. 
Keywords: Biomedical materials
Hydroxyapatite
Microemulsion
Nanoparticles
Processing
Issue Date: Oct-1996
Citation: Lim, G.K.,Wang, J.,Ng, S.C.,Gan, L.M. (1996-10). Processing of fine hydroxyapatite powders via an inverse microemulsion route. Materials Letters 28 (4-6) : 431-436. ScholarBank@NUS Repository.
Abstract: A submicrometer-sized hydroxyapatite powder has been synthesized via an inverse microemulsion processing route, which uses cyclohexane as the oil phase, mixed poly(oxyethylene)5 nonyl phenol ether (NP-5) and poly(oxyethylene)9 nonyl phenol ether (NP-9) as the surfactant phase, and an aqueous CaCl2 solution as the water phase. In comparison with the hydroxyapatite powder prepared by directly reacting (NH4)2HPO4 with CaCl2 in an aqueous solution, the microemulsion processing route led to a significant refinement in the particle size, particle size distribution, and the degree of particle agglomeration. XRD phase analysis indicates that a high-purity crystalline hydroxyapatite powder was obtained when the microemulsion-derived precursor was calcined at 800°C. In contrast, there existed impurity phases such as β-Ca3(PO4)2 and CaO in the conventionally processed hydroxyapatite powder after calcination at various temperatures up to 1200°C. This shows that the microemulsion processing route results in the formation of a more homogeneous ultrafine powder precursor than that obtained from the conventional processing route.
Source Title: Materials Letters
URI: http://scholarbank.nus.edu.sg/handle/10635/94622
ISSN: 0167577X
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

51
checked on Nov 9, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.